New NCI Director Plans Greater Support For Translational Research, Collaboration.
HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.
French Legion d’Honneur Bestowed On Hortobagyi.
Mammography Summit Planned For June In Milan.
Urgent Need For New Drugs To Treat Pre-Cancers: AACR.
Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.
FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.
American Home Products Changes Name To Wyeth.
Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored
